NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Amgen (NQ: AMGN)
236.74 USD  +0.75 (+0.32%)
Official Closing Price  /  Updated: 6:09 PM EST, Dec 13, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,041,100
Open 235.60
Bid (Size) 236.12 (1)
Ask (Size) 238.75 (1)
Prev. Close 235.99
Today's Range 235.14 - 238.12
52wk Range 166.30 - 238.12
Shares Outstanding 661,706,000
Dividend Yield 2.23%
Performance
YTD
+23.37%
+23.37%
1 Month
+7.77%
+7.77%
3 Month
+21.11%
+21.11%
6 Month
+34.45%
+34.45%
1 Year
+19.85%
+19.85%
Top News
More News
European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
First New Osteoporosis Medicine Approved in the European Union (EU) Since 2010 Read More
from PR Newswire
Amgen Announces 10% Increase In 2020 First Quarter Dividend
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the first quarter of 2020. The dividend will be paid on March 6, 2020, to all stockholders of... Read More
from PR Newswire
More News
Read More
Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting
from PR Newswire
Amgen Selects Location For R&D Facility In The South San Francisco Biotechnology Hub
from PR Newswire
Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease
from PR Newswire
Notable Thursday Option Activity: CAMP, AMGN, SKT
category Stocks
from Market News Video
Investors Are Heavily Buying These 19 Stocks
from Investor's Business Daily
January 2020 Options Now Available For Amgen (AMGN)
category Stocks
from Market News Video
3 Reasons This Biotech is a Buy for Risk-Averse Investors
category Market News , BGNE , AMGN
from Motley Fool
Here's Why You Should Own Amgen Stock in 2020
category AMGN , BGNE , BMY , and 1 more.
from Motley Fool
TQQQ, AAPL, CMCSA, AMGN: Large Inflows Detected at ETF
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.